Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline
about
Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung diseaseThe diagnosis of chronic obstructive pulmonary disease.Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls.α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke.Selected metabolic aspects of elastin and collagen fiber proteolysis in diseases of the respiratory system - the significance of α1 antitrypsin deficiency.Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil.Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.Alpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and management.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.Electronic Nose Technology in Respiratory Diseases.Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.[COPD-Management, a comprehensive review].Alpha-1 antitrypsin deficiency: outstanding questions and future directions.
P2860
Q22306038-0822DB96-44BA-49D5-859C-D13517AB1363Q27026678-212C9181-58B5-4DCD-86C2-BD49A39E4F9DQ34540664-39221012-88BE-4774-BF65-A90D6955A85BQ34922245-7EB6C8F4-D8CA-490D-851F-1B699E41AF87Q37012186-67974DF9-202E-4857-A48D-41D6A67D47C9Q37352149-666EED38-EE72-4BDA-8D21-7FD25C143016Q37392322-4C72E3BA-C148-46E9-A293-F5B8A001D413Q38114852-DA5F361C-D28D-462C-AC3B-979C54801035Q38457176-AFD4BDEC-16A3-4DCA-B252-175449D1A21FQ38937862-769A9BD4-0326-4E7E-9C3C-BF1222FBEA66Q39151252-4C5F6950-0992-4277-B4EE-0615A5298F20Q41138327-C3BA7082-4A00-4638-9B84-66312A4A1B72Q41614676-7591D1CC-C33A-4D8E-9F63-C4D636315C83Q49437744-113EE02F-BEEB-42CC-8CAE-C7530CB67449Q51791945-8C1BF422-B1AA-47C7-8854-C303DBBCCB11Q55666746-34134AC2-0963-462C-BEF7-BCD0B9B66787
P2860
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@ast
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@en
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@nl
type
label
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@ast
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@en
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@nl
prefLabel
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@ast
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@en
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@nl
P2093
P2860
P3181
P356
P1476
Alpha-1 antitrypsin deficiency ...... ty clinical practice guideline
@en
P2093
D E O'Donnell
D Goodridge
Darcy D Marciniuk
J Bourbeau
J L Lauzon
P2860
P304
P3181
P356
10.1155/2012/920918
P407
P577
2012-01-01T00:00:00Z